ArticleEuropean radiology2026
DSDFF-YOLO: an automated computer-aided diagnostic method for post-therapy radioiodine whole-body scan.
Article in European radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
objectivesRadioiodine-131 (
methodsThis retrospective study analyzed data from 361 thyroid cancer patients treated with
resultsThe validation set included 62 patients (mean age 43.90 ± 13.80 years [SD], 36 female patients). The DSDFF-YOLO outperformed others in detecting thyroid remnants and mLNs, achieving a mAP₅₀ of 0.772, mean precision of 0.801, and recall of 0.731. On the independent test set (51 patients, mean age 44.51 ± 15.51 years [SD], 22 female patients), it surpassed nuclear medicine physicians in detecting thyroid remnants and mLNs, with sensitivities of 85.53% and 79.31%, and specificities of 91.11% and 93.52%, respectively.
conclusionThe DSDFF-YOLO enabled effective and accurate automated auxiliary diagnosis based on RxWBS. This method demonstrated excellent diagnostic performance and holds significant potential for clinical application. KEY POINTS: Question Can Deep Learning effectively assist clinicians in accurately diagnosing whole-body lesions on post-therapy radioiodine whole-body scans, rather than remaining confined to cervical lesions? Findings The proposed model achieved high sensitivity and specificity in diagnosing lesions on post-therapy radioiodine whole-body scans, outperforming nuclear medicine physicians. Clinical relevance The proposed model was a promising automated diagnostic tool that could assist clinicians in accurately diagnosing lesions on post-therapy radioiodine whole-body scans, potentially reducing patients' need for costly SPECT/CT imaging.
Indexed as
Identifiers
42814122What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.